Model Informed Drug Development Archives | Page 9 of 42 | サターラ

Poster

Prediction of Enfuvertide Concentration-Time Profile in a Paediatric Population after Parenteral Administration Using a Physiologically Based Pharmacokinetic Model

Certara2019年8月23日

Poster

Simulating the effect of anti-diabetic drugs on ATP-sensitive potassium (KATP) channels inhibition in a human cardiac cell model (ORd)

Certara2019年8月23日

ポスター

Application of a PBPK model for prediction of the DDI between Lorazepam and Probenecid.

Certara2019年8月22日

Poster

What Sample Size to Use When Designing Paediatric Pharmacokinetic Studies? A Critical Analysis of “Precision Criteria”

Certara2019年8月22日

Poster

T4.1 – Setting the framework for database and development of this database

Certara2019年8月22日

Poster

Modelling Toxicodynamic Feedback is Critical in Recovering Toxicokinetics in Acetaminophen Overdose

Certara2019年8月9日

Poster

Development and Performance Evaluation of a semi-mechanistic PBPK Model for Topical Ocular Delivery of Pilocarpine and Timolol to Rabbit Eye

Certara2019年6月24日

Poster

Transporter inhibition: modelling in-vitro Transwell Assays

Certara2019年6月24日

White Paper

がん免疫療法の創薬と開発をQSPで最適化

A Quantitative Systems Pharmacology (QSP) approach for developing combination immune-oncology therapies can be used to…

Certara2019年6月19日

Brochure

Pirana　モデリングワークベンチ

Pirana is a flexible and extendible modeling workbench with an intuitive graphical user interface for…

Certara2019年5月28日

© 2025 Certara. All Rights Reserved. | 個人情報保護

Powered by Translations.com GlobalLink Web Software